2 December 2024 15:00 GMT Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 30 November 2024 the issued share capital of AstraZeneca PLC with voting rights is 1,550,317,189 ordinary shares of US$0.25. No …
